A group known as The Center for Stem Cell & Regenerative Medicine (CSCRM), which is comprised of Cleveland Clinic, Case Western Reserve university, University Hospitals, and Athersys Inc., has been awarded a $5 million grant from Ohio's Third Frontier Commission under the Research Commercialization program. This funding will help to support new and innovative stem cell technologies, and will include two commercial, for emerging, and three pilot projects. Each of the projects will match the funding, creating a $10 million grant to benefit stem cell and regenerative medicine within the state of Ohio.

These research efforts will result in efficient clinical applications, as well as the commercialization of stem cells to benefit patients located throughout Ohio. Thus far, these kinds of efforts have brought in $170 million in new commercial development and investment in the state.

Current healthcare is limited to using drugs or devices to treat disease and injury. Stem cell research such as that which is being done by CSCRM could change the way disease and injury are treated, as they are uniquely positioned to rapidly implement new stem cell technologies in both the commercial and therapeutic areas.

For additional information, visit the CSCRM website.